Neurology

Citations 101-110 of 245 total displayed.

Past content (since Jan 1998):

Original Articles
Incidence of Schizophrenia in a Nationwide Cohort of Patients With Type 1 Diabetes Mellitus

Hannu Juvonen; Antti Reunanen; Jari Haukka; Maria Muhonen; Jaana Suvisaari; Ritva Arajärvi; Timo Partonen; Jouko Lönnqvist
Arch Gen Psychiatry 2007; 64: 894-899. [Abstract] [Full text] [PDF]  

Original Articles
Polymorphisms of the Dopamine D₄ Receptor, Clinical Outcome, and Cortical Structure in Attention-Deficit/Hyperactivity Disorder

Philip Shaw; Michele Gornick; Jason Lerch; Anjene Addington; Jeffrey Seal; Deanna Greenstein; Wendy Sharp; Alan Evans; Jay N. Giedd; F. Xavier Castellanos; Judith L. Rapoport
Arch Gen Psychiatry 2007; 64: 921-931. [Abstract] [Full text] [PDF]  

Original Articles
Functional and Biochemical Alterations of the Medial Frontal Cortex in Obsessive-Compulsive Disorder

Murat Yücel; Ben J. Harrison; Stephen J. Wood; Alex Fornito; Robert M. Wellard; Jesus Pujol; Kerrie Clarke; Mary L. Phillips; Michael Kyrios; Dennis Velakoulis; Christos Pantelis
Arch Gen Psychiatry 2007; 64: 946-955. [Abstract] [Full text] [PDF]  

Original Articles
Olfactory Identification and Incidence of Mild Cognitive Impairment in Older Age

Robert S. Wilson; Julie A. Schneider; Steven E. Arnold; Yuxiao Tang; Patricia A. Boyle; David A. Bennett
Arch Gen Psychiatry 2007; 64: 802-808. [Abstract] [Full text] [PDF]  

Original Articles
Associations of Salivary Cortisol With Cognitive Function in the Baltimore Memory Study

Brian K. Lee; Thomas A. Glass; Matthew J. McAtee; Gary S. Wand; Karen Bandeen-Roche; Karen I. Bolla; Brian S. Schwartz
Arch Gen Psychiatry 2007; 64: 810-818. [Abstract] [Full text] [PDF]  

Commentaries
Cognitive Improvement in Response to Antipsychotic Drugs: Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

R. Walter Heinrichs
Arch Gen Psychiatry 2007; 64: 631-632. [Extract] [Full text] [PDF]  

Original Articles
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

Richard S. E. Keefe; Robert M. Bilder; Sonia M. Davis; Philip D. Harvey; Barton W. Palmer; James M. Gold; Herbert Y. Meltzer; Michael F. Green; George Capuano; T. Scott Stroup; Joseph P. McEvoy; Marvin S. Swartz; Robert A. Rosenheck; Diana O. Perkins; Clarence E. Davis; John K. Hsiao; Jeffrey A. Lieberman; for the CATIE Investigators and the Neurocognitive Working Group
Arch Gen Psychiatry 2007; 64: 633-647. [Abstract] [Full text] [PDF]  

Original Articles
Association Between Treatment-Emergent Suicidal Ideation With Citalopram and Polymorphisms Near Cyclic Adenosine Monophosphate Response Element Binding Protein in the STAR*D Study

Roy H. Perlis; Shaun Purcell; Maurizio Fava; Jesen Fagerness; A. John Rush; Madhukar H. Trivedi; Jordan W. Smoller
Arch Gen Psychiatry 2007; 64: 689-697. [Abstract] [Full text] [PDF]  

Original Articles
Levels of -Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment

Zhenyu Zhong; Michael Ewers; Stefan Teipel; Katharina Bürger; Anders Wallin; Kaj Blennow; Ping He; Carrie McAllister; Harald Hampel; Yong Shen
Arch Gen Psychiatry 2007; 64: 718-726. [Abstract] [Full text] [PDF]  

Original Articles
Cognition in Novice Ecstasy Users With Minimal Exposure to Other Drugs: A Prospective Cohort Study

Thelma Schilt; Maartje M. L. de Win; Maarten Koeter; Gerry Jager; Dirk J. Korf; Wim van den Brink; Ben Schmand
Arch Gen Psychiatry 2007; 64: 728-736. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25